+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rheumatoid Arthritis Diagnosis Tests: Global Strategic Business Report

  • PDF Icon

    Report

  • 393 Pages
  • January 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139951

Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $944.9 Million by 2030

In the changed post COVID-19 business landscape, the global market for Rheumatoid Arthritis Diagnosis Tests estimated at US$629.9 Million in the year 2022, is projected to reach a revised size of US$944.9 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2022-2030. Serology Tests, one of the segments analyzed in the report, is projected to record 5.5% CAGR and reach US$667.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Monitoring Ra Treatment Efficiency Tests segment is readjusted to a revised 4.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $129.4 Million, While China is Forecast to Grow at 6.5% CAGR

The Rheumatoid Arthritis Diagnosis Tests market in the U.S. is estimated at US$129.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$146.3 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 4.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Select Competitors (Total 65 Featured) -

  • Abbott Diagnostics
  • Augurex Life Sciences Corp.
  • Beckman Coulter, Inc.
  • Bio Rad Laboratories Inc.
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genway Biotech, Inc.
  • Microdrop LLC (imaware)
  • Qiagen NV
  • Siemens Healthcare GmbH
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc.

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Frequently Asked Questions about the Global Market for Rheumatoid Arthritis Diagnosis Tests

What is the estimated value of the Global Market for Rheumatoid Arthritis Diagnosis Tests?

The Global Market for Rheumatoid Arthritis Diagnosis Tests was estimated to be valued at $629.9 Million in 2022.

What is the growth rate of the Global Market for Rheumatoid Arthritis Diagnosis Tests?

The growth rate of the Global Market for Rheumatoid Arthritis Diagnosis Tests is 5.2%, with an estimated value of $944.9 Million by 2030.

What is the forecasted size of the Global Market for Rheumatoid Arthritis Diagnosis Tests?

The Global Market for Rheumatoid Arthritis Diagnosis Tests is estimated to be worth $944.9 Million by 2030.

Who are the key companies in the Global Market for Rheumatoid Arthritis Diagnosis Tests?

Key companies in the Global Market for Rheumatoid Arthritis Diagnosis Tests include Abbott Diagnostics, Augurex Life Sciences Corp., Beckman Coulter, Inc., Bio Rad Laboratories Inc., Exagen Inc., F. Hoffmann, La Roche Ltd., Genway Biotech, Inc., Microdrop LLC (imaware) and Qiagen NV.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Rheumatoid Arthritis Diagnosis Tests - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Rheumatoid Arthritis
  • Causes and Risk Factors
  • Symptoms
  • Rheumatoid Arthritis Diagnostic Tests
  • Serological Tests
  • Monitoring RA Treatment Efficiency Tests
  • Kidney Function Tests
  • Impact of Covid-19 and a Looming Global Recession
  • Impact of COVID-19 on Rheumatoid Arthritis Diagnostic Tests
  • Global Market Outlook and Prospects
  • Global Rheumatoid Arthritis Diagnostic Tests Market Set to Witness Significant Growth
  • Select RA Diagnostic Tests by Player
  • The US and Europe Dominate the Global Market, Developing Countries to Witness Fastest Growth
  • Competition
  • Recent Market Activity
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Rheumatoid Arthritis Propels the Demand for Rheumatoid Arthritis Diagnosis
  • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
  • Growing Aging Population to Drive the Demand for RA Diagnostic Tests
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Increasing Use of Rapid Diagnosis Tests Platform
  • Select List of RA Biomarkers used in Clinical Practice
  • Investigational Biomarkers to Diagnose and Monitor RA
  • New Biomarker Tests to Drive the Market Growth
  • More Specific Biomarker Tests
  • Growing Demand for Multiple Tests
  • Repercussions of Sub Optimal Accuracy in RA Testing Drive the Need for Multiple Tests
  • Recent Advancements in Treatment Methods to Boost Market Growth
  • Uptrend in Healthcare Expenditure Drives Opportunities
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
  • Increasing Obesity Levels Underpins Market Growth
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Technological Advancements Widen the Capabilities of RA Arthritis Tests
  • A Few of the Recent Launches and Advancements
  • Rapid RA Diagnostic Tests for Obtaining Results in Minutes
  • imaware™ Introduces At-Home Rheumatoid Arthritis Screening Test
  • Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test
  • Scipher Medicine® Ties Up with Ambry Genetics® to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
  • A New Blood Test Could to Predict Rheumatoid Arthritis
  • A New Blood Test Could to Predict Rheumatoid Arthritis
  • IPM Launches Innovative Program for Rheumatoid Arthritis
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Monitoring RA Treatment Efficiency Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Monitoring RA Treatment Efficiency Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Monitoring RA Treatment Efficiency Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Rheumatoid Arthritis Diagnosis Tests Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 17: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 18: World Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: World 16-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Rheumatoid Arthritis Diagnosis Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Diagnostics
  • Augurex Life Sciences Corp.
  • Beckman Coulter, Inc.
  • Bio Rad Laboratories Inc.
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genway Biotech, Inc.
  • Microdrop LLC (imaware)
  • Qiagen NV
  • Siemens Healthcare GmbH
  • Svar Life Science AB
  • Thermo Fisher Scientific Inc.